1-8 of 8
latent tuberculosis
Close
Sort by
Journal Articles

Clinical Features and Diagnostic Delay of Tuberculosis (TB) in Patients with Acute Myeloid Leukemia. (AML)

Veronica Bravo Villa, Hematology Fellow, Emmanuel Martínez Moreno, Hematology Fellow, Nidia Zapata, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5114.
https://doi.org/10.1182/blood-2019-128158
Published: 2019
Journal Articles

An Adaptive Design Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients with Non-Primary Hemophagocytic Lymphohistiocytosis

Veronica Asnaghi, MD, Maria Ballabio, MD, Philippe Jacqmin, Kathy de Graaf, Cristina De Min, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2333.
https://doi.org/10.1182/blood-2019-123995
Published: 2019
Journal Articles

Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population

Christianne Bourlon, MD, Oscar Manuel Fierro-Angulo, MD, Jesus A Garcia-Ramos, MD, Rocio Camacho-Hernandez, MD, Roberta Demichelis, MD, Aldo A Acosta-Medina, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3259.
https://doi.org/10.1182/blood-2019-131425
Published: 2019
Journal Articles

The Risk of Developing Tuberculosis in Cancer Patients Is Greatest in Lymphoma: A Large Population-Based Study

Chezi Ganzel, MD, Barbara Silverman, Daniel Chemtob, Assaf Ben Shoham, Yonit Wiener-Well
Journal: Blood
Blood (2017) 130 (Supplement 1): 3583.
https://doi.org/10.1182/blood.V130.Suppl_1.3583.3583
Published: 2017
Journal Articles

Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment

Yeo-Kyeoung Kim, MD, PhD, Se Ryeon Lee, MD, PhD, Yong Park, MD, PhD, Chul Won Choi, MD, PhD, Soo Jeong Kim, MD, PhD, Ho-Young Yhim, MD, PhD, Inho Kim, Doyeun Oh, MD, PhD, Yeung-Chul Mun, Sung-Nam Lim, MD, PhD, Jeong-A Kim, PhD, MD, Myung-Geun Shin, MD, PhD, Jong-Ho Won, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1596.
https://doi.org/10.1182/blood.V122.21.1596.1596
Published: 2013
Journal Articles

Final Results of a Phase II Danish Trial Testing Low Dose Total Body Irradiation Following Six Bi-Weekly RCHOP-14 Plus 2 Extra Rituximab in Elderly High risk Patients with Aggressive CD20+ Diffuse Large B-Cell Lymphoma (DLBCL).

Akmal Safwat, M.D., Lena Specht, M.D., Flemming Hansen, M.D., Mads Hansen, M.D., Jesper Jurlander, M.D., Francesco d’Amore, MD
Journal: Blood
Blood (2008) 112 (11): 1013.
https://doi.org/10.1182/blood.V112.11.1013.1013
Published: 2008
Journal Articles

Early Results of a Phase II Trial Testing Low Dose Total Body Irradiation (LTBI) after Chemoimmunotherapy in Elderly High Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Akmal Safwat, MD, Lena Specht, M.D., Flemming Hansen, M.D., Mads Hansen, M.D., Jesper Jurlander, M.D., Anne Marie Boesen, M.D., Francesco d’Amore, M.D.
Journal: Blood
Blood (2007) 110 (11): 1296.
https://doi.org/10.1182/blood.V110.11.1296.1296
Published: 2007
Journal Articles

Hydroxyurea Utilization in Nigeria, a Lesson in Public Health.

Zakari Y. Aliyu, MD, MPH, Aliyu Babadoko, MBBS, Aisha Mamman, MBBS
Journal: Blood
Blood (2007) 110 (11): 80.
https://doi.org/10.1182/blood.V110.11.80.80
Published: 2007